What aspects of illness influence public preferences for healthcare priority setting? A discrete choice experiment in the UK
MORRELL E. et al, (2021), PharmacoEconomics
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
Wei J. et al, (2021), Nature Microbiology
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time
Walker AS. et al, (2021), eLife, 10
Incentive preferences for community health volunteers in Kenya: findings from a discrete choice experiment
Abuya T. et al, (2021), BMJ Open, 11, e048059 - e048059
Cost-effectiveness of amphotericin B deoxycholate versus itraconazole for induction therapy of talaromycosis in HIV-infected adults in Vietnam
BUCHANAN J. et al, (2021), Open Forum Infectious Diseases
Does bariatric surgery reduce future hospital costs? A propensity score-matched analysis using UK Biobank Study data.
Wu T. et al, (2021), Int J Obes (Lond)
Clinical utility of whole-genome sequencing in precision oncology.
Rosenquist R. et al, (2021), Semin Cancer Biol
Correction to: Toward the diagnosis of rare childhood genetic diseases: what do parents value most?
Pollard S. et al, (2021), European journal of human genetics : EJHG
Genetic-guided pharmacotherapy for venous thromboembolism: a systematic and critical review of economic evaluations
Lim KK. et al, (2021), The Pharmacogenomics Journal
Progressive exercise versus best practice advice, with or without corticosteroid injection, for rotator cuff disorders: the GRASP 2x2 factorial RCT and economic evaluation
HOPEWELL S. et al, (2021), Health Technology Assessment
Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom.
Pritchard E. et al, (2021), Nature medicine
Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom.
Pritchard E. et al, (2021), Nat Med
IT Evaluation of Foundation Healthcare Group Vanguard Project.
Tapuria A. et al, (2021), Stud Health Technol Inform, 281, 625 - 629
Program Evaluation of Population- and System-Level Policies: Evidence for Decision Making.
Walker S. et al, (2021), Med Decis Making
Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status
EYRE D. et al, (2021), Clinical Microbiology and Infection
Impact of vaccination on new SARS-CoV-2 infections in the UK
PRITCHARD E. et al, (2021), Nature Medicine
A systematic review of economic aspects of service interventions to increase anticoagulation use in atrial fibrillation
JONES N. et al, (2021), Thrombosis and Haemostasis